The European Risk Surveillance for Prostate Cancer (ERSPC) is one such risk calculator that generates two risk predictions, one for all prostate cancers and one for clinically significant cancers, based on information such as age, DRE, PSA, prostate volume, and previous negative biopsies. The gene discussed is KLK3; the disease is prostate carcinoma.